ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms.

Antje Lindemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.